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The set of alcohol-metabolizing enzymes has considerable genetic and functional complexity. The relationships
between some alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) genes and alcohol dependence
(AD) have long been studied in many populations, but not comprehensively. In the present study, we genotyped
16 markers within the ADH gene cluster (including the ADH1A, ADH1B, ADH1C, ADH5, ADH6, and ADH7
genes), 4 markers within the ALDH2 gene, and 38 unlinked ancestry-informative markers in a case-control sample
of 801 individuals. Associations between markers and disease were analyzed by a Hardy-Weinberg equilibrium
(HWE) test, a conventional case-control comparison, a structured association analysis, and a novel diplotype trend
regression (DTR) analysis. Finally, the disease alleles were ﬁne mapped by a Hardy-Weinberg disequilibrium (HWD)
measure (J). All markers were found to be in HWE in controls, but some markers showed HWD in cases. Genotypes
of many markers were associated with AD. DTR analysis showed that ADH5 genotypes and diplotypes of ADH1A,
ADH1B, ADH7, and ALDH2 were associated with AD in European Americans and/or African Americans. The
risk-inﬂuencing alleles were ﬁne mapped from among the markers studied and were found to coincide with some
well-known functional variants. We demonstrated that DTR was more powerful than many other conventional
association methods. We also found that several ADH genes and the ALDH2 gene were susceptibility loci for AD,
and the associations were best explained by several independent risk genes.
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Several linkage studies, including the Collaborative
Study on the Genetics of Alcoholism,1–4 a study by in-
vestigators at the National Institute on Alcohol Abuse
and Alcoholism,5 and a study involving Mission Indi-
ans,6 have provided evidence supporting the localization
of a risk locus or loci for alcohol dependence (AD [MIM
103780]) to a region harboring the alcohol dehydro-
genase (ADH) gene cluster at chromosome 4q21-25 (re-
viewed by Luo et al.7). One or more risk alleles at the
ADH gene cluster may directly predispose to AD. To
identify these risk alleles, association studies using link-
age disequilibrium (LD) mapping methods are most
commonly used, which include case-only association
designs,7 case-control association designs, and family-
based association designs.
Both case-only designs (using a Hardy-Weinberg dis-
equilibrium [HWD] test) and case-control designs can
be valid association and ﬁne-mapping methods. How-
ever, both designs are vulnerable to population stratiﬁ-
cation that could result in spurious ﬁndings. We there-
fore used a structured association (SA) method based on
a case-control design, a novel method developed by Prit-
chard et al.,8 to exclude population stratiﬁcation and
admixture effects on associations. This method and re-
lated methods have been applied in several previous
studies.e.g.,9–12 However, this method also has its limita-
tions: (1) it does not take gene-gene interactions into
account, and (2) it cannot accurately analyze haplotype
data when some individuals have uncertain haplotype
pairs (which are always observed when statistical infer-
ence is used to reconstruct haplotypes). The present
study aims to extend this SA approach and to overcome
its limitations by developing a novel method, which we
call “diplotype trend regression” (DTR) analysis, a
method similar to haplotype trend regression,13 that ex-
tends our previous application.11
Certain ADH variants are among the best-knownAD-
vulnerability genes (table 1). This set of genes with par-
tially redundant function may have created a situation
relatively tolerant of functional variation in individual
genes. Seven ADH genes at the ADH gene cluster are
located so close together within an ∼364-kb region (ﬁg.
1) that the LD between them cannot be neglected. Dif-
ferent markers within the same ADH gene could also,
of course, be in strong LD. Furthermore, the expression
products of different ADH genes—that is, the ADH iso-
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Table 1
Positive Associations between the ADH and ALDH Genes and AD in Different Populations
Gene or Allele Positive Finding Population(s) Reference(s)
SNP16*Arg (ADH2*1) allele Increases risk for AD Japanese, Chinese 6, 14–26
SNP16*His (ADH2*2)
or SNP14*Cys (ADH2*3) allele
Protects against AD Taiwan Atayal natives, Chinese,
Europeans, Jews, AAs
6, 14–26
SNP17*Ile (ADH3*1) allele Protects against AD Chinese, Europeans 16, 20, 21, 23, 27, 28
SNP17*Val (ADH3*2) allele Increases risk for AD Chinese, Mexican Americans,
American Indians
16, 20, 21, 23, 27, 28
ALDH2*1 allele Increases risk for AD Chinese, Japanese 20, 29–32
ALDH2*2 allele Protects against AD East Asians, Asian Americans 20, 29–32
ADH5 gene Two markers related to AD … 33
ADH4 gene Several variants associated with AD EAs, Brazilians 34, 35
ADH7 gene Epistatic role in protecting against AD Asians (majority) 36
enzymes—have similar amino acid sequences, structures,
and properties, co-contributing to liver or stomachADH
activity, with only minor differences in preferred sub-
strates.37–41 Therefore, theoretically, there may be inter-
actions among different ADH genes that cause epistasis.
For example, ADH1B (MIM 103720) and ADH1C
(MIM 103730) have long been considered to be inde-
pendent genes inﬂuencing risk of alcohol dependence,
but Chen et al.29 and Osier et al.14 claimed that, on the
basis of stratiﬁcation analysis or regression analysis,
the contribution to risk of alcoholism represented by
ADH1C∧SNP17 (Ile/Val) might actually be attributable
to LD with ADH1B∧SNP16 (Arg/His). Additionally,
there may be strong physiological interactions between
ADH genes and aldehyde dehydrogenase (ALDH) genes,
because they appear to have the potential to exert mul-
tiplicative effects during the metabolism of alcohol: the
ADHs convert alcohol to acetaldehyde, and then the
ALDHs quickly convert acetaldehyde into acetate. Ac-
etate is then oxidized via the tricarboxylic acid cycle to
yield CO2 and H2O.
Detection of gene-gene interactions among different
ADH and ALDH genes is important for two main rea-
sons. (1) Identifying an interaction will increase our un-
derstanding of the mechanisms through which the genes
act to control expression of the trait; ignoring a true
gene-gene interaction in an analysis can, erroneously,
make the main effects of the genes appear nonsigniﬁ-
cant.42 (2) Failing to model a gene-gene interaction in
an analysis can lead to incorrect conclusions with respect
to determination of the mode of inheritance and esti-
mation of the magnitude of genetic effects.43,44 Thus,
these marker-marker or gene-gene interactions should
not be neglected. When gene-gene interactions are de-
tected, we evaluate the strength of these interactions and
study the effect of each gene by controlling for the in-
teraction effects on the trait. One common analytic
method to study gene-gene interaction effects is called
“stratiﬁcation analysis” (discussed by Luo et al.11).How-
ever, stratiﬁcation analysis, through subsetting the sam-
ple, reduces statistical power for the identiﬁcation of
interactions. Another common analytic method to study
gene-gene interaction effects is regression analysis,which
directly models all the variables in a single analysis,
thereby increasing the statistical power.11,45–48 DTR is one
such regression model (see the “Material and Methods”
section).
Because a multilocus haplotype incorporates the LD
information from single markers and also might re-
ﬂect additional information from unknown neighboring
markers, it has the potential to provide more informa-
tion in association analysis than any single marker. But
inevitably, unambiguous haplotype pairs will often be
unavailable if statistical inference is used to reconstruct
haplotypes. In the analysis, if we use the most likely pair
(i.e., the “best pair”) of haplotypes (“reduced mode”)—
which has the highest probability among all the inferred
uncertain haplotype pairs in each individual—so that we
can use an existing analytic method such as SA (which
requires that each individual’s haplotype be identiﬁed),
the bias may become signiﬁcant, including LD overes-
timation and biased estimates of haplotype effects. If we
use all possible haplotype pairs inferred (“full mode”),
which may have different probabilities in one individual,
the bias will be maximally reduced, and the results will
therefore be a better approximation of the truth. We are
not aware of any previously existing analytic method
that can use this “full mode” of haplotype pairs.
Disease is a natural-selection factor; this can be re-
ﬂected in HWD at a disease locus, or in markers in LD
with the disease locus. One may observe HWD at a locus
when an association exists between that locus and dis-
ease.7 Under HWD, alleles at a locus are not independent
of each other, and this may invalidate allelewise analysis
of that locus.7,49 A multilocus haplotype is actually the
subset of every single-locus allele; both allele and hap-
lotype reﬂect the features of chromosomes in the pop-
ulation. Thus, under HWD, haplotypewise analysis may
also be invalid. In this situation, genotypewise analysis
may be the only way to draw fully valid conclusions. A
diplotype (i.e., a haplotype pair) is the subset of every
single-locus genotype; both genotype and diplotype rep-
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Figure 1 ADH gene cluster
resent the types of chromosome pairs in each individual.
Therefore, under HWD, diplotypewise analysis may be
a valid and maximally informative method.We also note
that, under a recessive mode of inheritance, genotype-
wise and diplotypewise analyses should be consider-
ably more powerful than allelewise and haplotypewise
analyses.7,12 DTR is a diplotypewise analytic method (see
the “Material and Methods” section).
In summary, in the present study, we used a DTR
method that controls for any population stratiﬁcation
and admixture effects, allows for unknown haplotype
phase, takes marker-marker and gene-gene interactions
into account, obviates the need for Hardy-Weinberg
equilibrium (HWE), and avoids multiple testing due to
consideration of multiple populations, multiplemarkers,
and multiple genes.
Many studies have shown positive associations be-
tween the ADH1B, ADH1C, ADH5 (MIM 103710),
ADH4 (MIM 103740), ADH7 (MIM 600086), and
ALDH2 (MIM 100650) loci and AD within speciﬁc
populations or have shown consistent positive ﬁndings
across different populations (e.g., see table 1). For the
present study, we investigated associations between AD
and all ADH genes (except ADH4, which we studied
previously and reported elsewhere7,12) and ALDH2 in
European Americans (EAs) and African Americans
(AAs), the two most common distinct populations in the
United States, and tested the population speciﬁcity of
any detected associations, using DTR.
Material and Methods
Subjects
A total of 801 unrelated subjects were included in this study,
as described elsewhere.11 This sample includes two different
populations (651 EAs and 150 AAs; the populations were clas-
siﬁed by statistical determination of ancestry proportions, as
discussed below), comprising 365 healthy controls (317 EAs
and 48 AAs) and 436 cases (334 EAs and 102 AAs) and in-
cluding both females ( ) and males ( ). Thenp 324 np 477
cases met lifetime DSM-IIIR or DSM-IV criteria50,51 for AD.
The control subjects were screened to exclude major axis I
mental disorders, including substance-use disorders, psychotic
disorders (including schizophrenia or schizophrenia-like dis-
orders), mood disorders, and major anxiety disorders. Males
constituted 75.9% of the cases and 40.0% of the controls. The
average ages were years for controls and28.1 9.1 40.3
years for cases. The subjects were recruited at the Univer-9.2
sity of Connecticut Health Center or at the VA Connecticut
Healthcare System, West Haven Campus. All subjects gave
informed consent before participating in the study, which was
approved by the institutional review board at each institution.
Marker Selection
The present study aimed to create a basis for a future ﬁne-
mapping study with denser sets of markers at each potential
risk gene. These markers were selected because (1) they were
available from and validated by Applied Biosystems (ABI) or
were studied in a prior publication (e.g., four ALDH2markers
were selected from the study by Peterson et al.52) or (2) they
had previously been reported to be associated with AD. After
validation by PCR and allele-frequency evaluation in our sam-
ple, one ADH5 marker (located in a haplotype block that
covers 80% of the full length of ADH5 [according to the ABI
SNP and haplotype database]), one ADH6 (MIM 103735)
marker (located in a haplotype block that covers 100% of the
full length of ADH6), three ADH1A (MIM 103700) markers,
four ADH1B markers, three ADH1C markers, four ADH7
markers, and four ALDH2 markers were ultimately included
(table 2). Seven ADH4 markers were studied previously.7,12
Although the results with respect to phenotype have been re-
ported elsewhere, these data were included in this study for
LD analysis. All the rs numbers for these markers were avail-
able from the SNP database (dbSNP).
Thirty-eight ancestry-informative markers (AIMs) unlinked
to the ADH and ALDH genes, including 37 STRs and one
Duffy antigen gene (FY) marker (rs2814778), were genotyped
to detect the population structure of our sample. These marker
sets were employed in many previous studies,9–12 and their
characteristics have been described elsewhere53 in a report that
included many of the subjects in the present study.
Genotyping
By TaqMan technique.—Genomic DNA was extracted from
peripheral blood by standard methods. Most SNPs were ge-
notyped with a ﬂuorogenic 5′-nuclease assay method: the
TaqMan technique.54 PCR conditions were described else-
where.7 All genotyping was performed in duplicate, and results
were compared to ensure validity of the data. Mismatched
genotypes, which constituted !0.5% of the total number of
duplicate genotypes performed, were discarded.
By PCR-RFLP technique.—Three ADH1B markers, one
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Table 2
Information and Genotyping Methods for ADH and ALDH2 Gene Markers
Marker Alias
rs
Number Chromosome Position
Distancea
(bp) Substitution
Amino
Acid Location
Genotyping
Technique
ADH5∧SNP1 … rs1154400 4 100468404 0 C/T … Exon 1 Assays-on-Demand
ADH4∧SNP2 … rs6532795 4 100500615 32,211 T/C … 3′ Assays-on-Demand
ADH4∧SNP3 … rs1042364 4 100503968 3,353 G/A Gly/Arg Exon 10 Assays-on-Demand
ADH4∧SNP4 … rs1126671 4 100506808 2,840 G/A Val/Ile Exon 8 Assays-by-Design
ADH4∧SNP5 … rs1126670 4 100511127 4,319 T/G Pro/Pro Exon 7 Assays-on-Demand
ADH4∧SNP6 … rs7694646 4 100518126 6,999 A/T … Intron 5 Assays-on-Demand
ADH4∧SNP7 A75C rs1800759 4 100523903 5,777 A/C … Promoter Assays-on-Demand
ADH4∧SNP8 … rs1984362 4 100529367 5,464 C/T … 5′ Assays-on-Demand
ADH6∧SNP9 … rs13104485 4 100599217 69,850 A/T … 3′ Assays-on-Demand
ADH1A∧SNP10 … rs6837311 4 100653667 54,450 A/T … 5′ Assays-on-Demand
ADH1A∧SNP11 … rs975833 4 100660133 6,466 C/G … Intron 7 Assays-on-Demand
ADH1A∧SNP12 … rs1229966 4 100671827 11,694 A/G … 3′ Assays-on-Demand
ADH1B∧SNP13 … rs1042026 4 100686860 15,033 C/T … Exon 11 Assays-on-Demand
ADH1B∧SNP14 ADH2*1/3 rs2066702 4 100687411 551 C/T Arg/Cys Exon 10 PCR-RFLPb
ADH1B∧SNP15 C96T rs2066701 4 100696807 9,396 C/T … Intron 3 PCR-RFLPc
ADH1B∧SNP16 ADH2*1/2 rs1229984 4 100697713 906 G/A Arg/His Exon 4 PCR-RFLPd
ADH1C∧SNP17 ADH3*1/2 rs698 4 100719183 21,470 A/G Ile/Val Exon 9 PCR-RFLPe
ADH1C∧SNP18 … rs1693482 4 100722359 3,176 A/G Gln/Arg Exon 7 Assays-by-Design
ADH1C∧SNP19 … rs1693427 4 100725221 2,862 C/T … Intron 4 Assays-on-Demand
ADH7∧SNP20 … rs284786 4 100792371 67,150 A/T … Exon 11 Assays-on-Demand
ADH7∧SNP21 … rs971074 4 100800255 7,884 C/T Arg/Arg Exon 7 Assays-on-Demand
ADH7∧SNP22 … rs1573496 4 100808063 7,808 C/G Ala/Gly Exon 4 Assays-by-Design
ADH7∧SNP23 … rs1154470 4 100814731 6,668 A/G … Intron 2 Assays-on-Demand
ALDH2∧SNP24 G355A rs886205 12 110667147 …f G/A … 5′ PCR-RFLPg
ALDH2∧SNP25 T348C rs440 12 110691434 24,287 T/C … Intron 6 PCR-RFLPg
ALDH2∧SNP26 T483C rs11613351 12 110691512 78 T/C … Intron 6 PCR-RFLPg
ALDH2∧SNP27 G69A rs4646777 12 110692756 1,244 G/A … Intron 8 PCR-RFLPg
a Map distance between markers.
b Primers: AGCTGGGATCACAGACAGATTT and GGCATCTCTATTGCCTCAAAAC; restriction endonuclease: AlwNI.
c Primers and restriction endonuclease are the same as those used by Osier et al.14
d Primers: AATCTTTTCTGAATCTGAACAG and TTGCCACTAACCACGTGGTCATCTGcG; restriction endonuclease: HhaI.
e Primers: ACCTCTTTCCAGAGCGAAGCAG and CTTTAAGAGTAAAGATCTGTCC; restriction endonuclease: SspI.
f Located at different chromosomes.
g Primers and restriction endonuclease are the same as those used by Peterson et al.52
ADH1C marker, four ALDH2 markers, and one FY marker
were genotyped by PCR-RFLP. The FY marker (rs2814778),
highly informative for the ethnic ancestry of the subject, was
genotyped by a PCR-RFLP technique as described elsewhere.55
Approximately 8% of genotypes on each plate cohort were ge-
notyped again for quality control, with complete concordance.
By ﬂuorescence capillary electrophoresis technique.—The 37
STR markers were genotyped by a ﬂuorescence capillary elec-
trophoresis technique with the ABI PRISM3100 semiautomated
capillary ﬂuorescence sequencer, as described elsewhere.53
Statistical Analysis
LD analysis.—Pairwise LD between any two ADH orALDH2
gene markers was analyzed separately by population (EAs and
AAs). The D′ value for each LD pair was calculated and vi-
sualized using the program Haploview56 (ﬁg. 2).
HWE test.—HWE was tested within populations and sep-
arately in cases and controls, by use of an exact test of goodness
of ﬁt that is implemented in the program PowerMarker, version
3.0; P values are shown in table 3. Deviation from HWE ex-
pectations (i.e., HWD) in cases can indicate a valid disease-
gene association.
Genotype frequency analysis.—Allele and genotype fre-
quencies of the ADH and ALDH2 markers among EAs and
AAs are shown in table 4. Genotype-phenotype associations
were tested using exact tests (2 df) in the program Power-
Marker; P values are listed in table 5.
Fine mapping the risk alleles.—HWD of a marker in cases
sometimes indicates a valid gene-phenotype association, es-
pecially when the marker is in HWE in controls.7,11 Thus,
HWD measures can be used for ﬁne mapping a risk locus—
ideally, in the situation where markers are in HWD in cases
but in HWE in controls, as was often the case in the present
study (table 3) and in the study by Luo et al.7 Many measures
of HWD in case-only samples have been advanced for this
purpose, including F, , J, and .57,58 Among these, J is the′ ′F J
preferred disequilibrium measure for ﬁne mapping, because it
is a direct decreasing function of the recombination fraction
between the disease and the marker loci and does not depend
on allele frequencies of the disease and marker loci. J can be
derived from the genotype frequency data but not from the
Figure 2 LD analysis for ADH and ALDH2 markers in EAs and AAs. a, ADH genes in EAs. b, ADH genes in AAs. c, ALDH2 gene in EAs or AAs.
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Table 3
P Values for HWE Tests in Cases
MARKER
P
EAs AAs
ADH5∧SNP1 .037 .058
ADH1B∧SNP16 .0001 1.10
ADH1C∧SNP17 1.10 .012
ADH1C∧SNP18 .055 .035
ADH1C∧SNP19 .061 .056
ADH7∧SNP22 1.10 .016
ADH7∧SNP23 1.10 .091
NOTE.—Markers with inP 1 .10
all phenotype groups are not listed.
Table 4
Genotype and Allele Frequencies in EAs and AAs
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
allele frequency data.7,58 If there are several peak J values in
the ADH gene cluster, this might suggest that there are several
risk alleles for disease within that cluster (ﬁg. 3). Therefore,
among the many HWD measures, this statistic is best suited
for ﬁne mapping in the present application.
Population structure analysis.—The two most common ge-
netically distinguishable populations in the United States—EAs
and AAs—have their origins in ancestral populations that mi-
grated from multiple geographic locations in Europe and Af-
rica, respectively. Both populations have admixture histories
in recent generations in the United States, although the ad-
mixture rate for EAs is much lower than that for AAs. As
reported elsewhere,59,60 AAs are admixed primarily with EAs,
and some EA individuals have (usually small) proportions of
African ancestry. Thus, both of these populations were treated
as potentially admixed populations in the present study.
Even when the statistical analysis is conducted separately
for EAs and AAs, population stratiﬁcation could still have an
effect on the analysis, because admixture within these two
populations could still produce spurious LD block size, confuse
HWD tests, or cause spurious associations. Pritchard et al.8
and Falush et al.61 developed a software program, STRUC-
TURE, based on a model-based clustering method, that can
infer ancestry proportions of an admixed sample to detect its
underlying population structure by use of information from
unlinked AIMs. For this purpose, we selected 38 AIMs, in-
cluding 37 STR markers and 1 FY marker. The suitability of
these AIMs for detecting the presence of population structure,
their adequacy for providing information for assigning all in-
dividuals into different genetic ancestral populations, and the
feasibility of validly analyzing them with the program STRUC-
TURE have already been demonstrated bymany previous stud-
ies.9–12,53 These 38 AIMs are unlinked to each other and to the
ADH and ALDH2 genes. All AIMs were in HWE, and there
was no LD among these AIMs, nor was there association be-
tween the AIMs and any phenotype. These AIMs are appro-
priate for detection of population structure without signiﬁcant
bias. More details of the features of this set of AIMs are pro-
vided elsewhere.12,53
To estimate the ancestry proportions of the subjects more
accurately, all subjects were studied together as a single “ad-
mixed” sample. Parameter settings for running STRUCTURE
are reported elsewhere.12
SA analysis.—In admixed populations, each individual may
have ancestries from different populations, and the ancestry
proportions may vary among individuals, which can cause
spurious ﬁndings in association analysis. By stratifying the ad-
mixed population to nonadmixed subpopulations and then
performing the association analysis within these subpopula-
tions, spurious ﬁndings can be avoided; or, by conditioning
the association analysis on the ancestry proportions of each
subject, the admixture effects can be accounted for statistically
and thereby eliminated. Conversely, correction of the spurious
associations—for example, elimination of the associations be-
tween the 38 unlinked AIMs and any phenotypes—also in-
dicates that the admixed populations have been successfully
structured or that the admixture effects have been successfully
controlled. This can be achieved by an SA analysis performed
using the program STRAT.62 (Parameter settings for running
STRAT are described elsewhere.12) It should be noted that the
association analysis was limited to the genotypewise level, not
the allelewise level, because of HWD existing among the ADH
and ALDH2 markers. This SA method is also not suitable for
the unphased diplotype data.
Haplotype reconstruction.—The expectation-maximization
(EM) algorithm, as employed by many programs that recon-
struct estimated haplotypes, assumes HWE. But, in our study,
the genotype frequency distributions of many markers were in
HWD in the cases (table 3), which violates the assumption of
the EM algorithm. This may increase the error of EM esti-
mates, especially when the HWD is attributable to an excess
of the expected heterozygote frequency over that observed.63
The Bayesian approach and the partition-ligation algorithm
that the program PHASE is based on have been claimed to be
more accurate in reconstructing haplotypes than the EM al-
gorithm and are valid even under HWD.64–66 Consequently, we
applied PHASE to reconstruct haplotypes and to estimate the
diplotype (haplotype pair) probabilities for each subject in the
present study. Parameter settings for running PHASE are pre-
sented elsewhere.12 Haplotypes were reconstructed for “ge-
netic” EAs (European ancestry proportion 10.5) and AAs (Af-
rican ancestry proportion 10.5) rather than self-reported EAs
and AAs. In the present study, all analyses conducted sepa-
rately by population were performed using “genetic” EAs and
AAs rather than self-reported EAs and AAs.
Alleles at the ADH gene markers that map to the cluster on
chromosome 4, especially those within the same haplotype
block (e.g., alleles at ADH6, ADH1A, and ADH1B) (ﬁg. 2),
can be “put” in the same haplotype, but we constructed hap-
lotypes only within single genes because we wanted to differ-
entiate haplotype effects among different genes. (Alternatively,
interactions between different genes were considered via the
regression methods described below.)
Gene-gene interaction analysis.—Pairwise LD analysis be-
tween markers can direct us to the observation of marker-
marker correlation. However, single markers usually cannot
fully reﬂect the information for an entire gene. Haplotype-
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Table 5
P Values of Comparisons for Genotype Frequency
Distributions between Cases and Controls in EAs
and AAs
MARKER
P BEFOREa P AFTERb
EAs AAs EAs AAs
ADH1A∧SNP11 1.10 1.10 1.10 .075
ADH1B∧SNP14 NA .012 NA .004
ADH1B∧SNP16 .001 1.10 .007 1.10
ADH1C∧SNP17 1.10 .040 1.10 1.10
ADH1C∧SNP18 1.10 .025 1.10 .056
ADH1C∧SNP19 1.10 .068 1.10 1.10
ADH7∧SNP20 1.10 .068 1.10 .068
NOTE.—Markers with in all phenotypeP 1 .10
groups are not listed. NA p not applicable.
a “Before” refers to conventional case-control com-
parison before admixture effects are controlled for.
b “After” refers to case-control comparison after
admixture effects are controlled for (SA analysis).
haplotype or diplotype-diplotype interactions might be more
representative of gene-gene interaction. Haplotypes or diplo-
types themselves incorporate the marker-marker LD infor-
mation. A multilocus haplotype or diplotype is actually the
subset of an allele or a genotype of a single marker, so hap-
lotype or diplotype analysis is actually equivalent to stratiﬁ-
cation analysis of every single marker,67 with the correlations
among single markers already incorporated. Thus, the use of
haplotype or diplotype data obviates the analysis of marker-
marker interaction effects. Haplotypes or diplotypes are mu-
tually exclusive in structure (i.e., no two haplotypes can be
located on the same chromosome), and interactions among
them may reﬂect their joint effects on the trait. To study cor-
relations among diplotypes at different genes, a Pearson cor-
relation analysis can be performed between any two diplotypes
(a similar procedure was used by Dong et al.68). Correlation
analysis on single markers can be used as a valid LDmeasure.69
Strong correlation between two intergene diplotypes suggests
that these two diplotypes may have additive, or multiplicative,
effects on the trait. Strong correlation between two within-
gene diplotypes suggests that these two diplotypes may have
similar effects on trait. Any two diplotypes within the same
gene that are highly correlated can be combined as a single
variable in the DTR model (if the variance inﬂation factor is
110),70 or the interactions between them should be considered
if they are not combined as a single variable in DTR. Only
the interactions between those diplotypes having correlations
with and were considered in DTR.r 1 0.9 P ! .01
Determined by statistical inference but not molecular ex-
perimentation, the inferred haplotype probability in each in-
dividual is usually not equal to 1.0; uncertainty remains. Thus,
most individuals have several possible diplotypes even within
one gene, which can be described as follows (“full mode”):
the individual has a% of diplotype A (i.e., the probability is
a% that A is the correct diplotype), b% of diplotype B, and
of diplotype C (if there are three possible[100 (a b)]%
diplotypes). Supposing this individual’s true diplotype is A,we
can look at it as a special case of the “full mode”—that is,
the individual has 100% of diplotype A, 0% of diplotype B,
and 0% of diplotype C. Thus, this method of analysis ﬁts for
any certain or uncertain diplotype data.
DTR analysis.—A backward stepwise logistic regression
analysis implemented in SPSS, version 13.0, was used to test
associations between genes and diseases within “genetic” EAs
and AAs (see the regression model elsewhere11,12). Backward
regression variable selection was applied. In the regression
model, phenotypes served as the dependent variables, and the
covariates included ancestry proportion, age, sex, genotype
probabilities at ADH5 and ADH6 (we only genotyped one
SNP at each of these two genes), diplotype probabilities at
other genes, and interactions among genotypes or diplotypes.
Age and sex were included because they were highly asym-
metrically distributed between cases and controls and therefore
could potentially confound the association analysis. Ancestry
proportions were included in the model to control for popu-
lation stratiﬁcation and admixture effects. Genotype and di-
plotype probabilities were included, but allele and haplotype
probabilities were excluded because of HWD.7 Genotypes at
ADH5 andADH6 and diplotypes at other genes can be entered
into a single DTR model, because genotypes can be taken as
supersets of diplotypes.
In the regression model, phenotype and sex are categorical
variables, whereas ancestry proportion, age, genotype prob-
ability, and diplotype probability are continuous variables. The
use of continuous variables, such as proportions and proba-
bilities, preserves more information than does the use of cat-
egorical variables, such as population categories, genotype cat-
egories, and diplotype categories. We named this regression
analysis that uses diplotype probability as the predictor vari-
able “diplotype trend regression” (DTR) analysis, analogous
to haplotype trend regression.13
(As an alternative to this DTR analysis, an even more com-
plete analysis of “full mode” would involve the use of a true
complete mixture model,71,72 in which the probabilities of var-
ious diplotypes for each person are considered in the analysis.
This was beyond the scope of the present study.)
Results
ADH markers were located in several haplotype blocks,
whereas ALDH2 markers were in one haplotype block
(ﬁg. 2). Twenty-three ADH markers span 346,327 bp,
covering 95% of the full length of the ADH gene cluster
(364,128 bp) on chromosome 4, with an average inter-
marker distance of 15 kb (table 2). LD between ADH
markers differs substantially between EAs and AAs (ﬁg.
2a and 2b). Pairwise LD analysis showed that three
ADH1C markers belong to one haplotype block ( ′D 1
) in both EAs and AAs. The seven ADH4 markers0.9
also belong to one haplotype block in both EAs and AAs
(as described by Luo et al.7). The sets of markers at
ADH6, ADH1A, and ADH1B belong to one haplotype
block in EAs, and three markers at ADH7 belong to
another haplotype block in EAs, but these markers do
not deﬁne any haplotype blocks in AAs. (Markers were
in much weaker LD in AAs than in EAs, possibly because
AAs are an older population in which recombination
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Figure 3 Fine mapping the risk alleles at the ADH gene cluster in EA cases on the basis of J values. The X-axis represents the marker
names; the Y-axis represents the J values. Marker numbers (which do not include markers mapped to the ADH4 gene) correspond to the order
presented in table 2. The marker ADH1B∧SNP16 (i.e., ADH2*Arg/His, with the highest J value) is included in the left ﬁgure but excluded in
the right ﬁgure (to enlarge the scale of the Y-axis).
may have had more time to reduce haplotype block size.)
In both EAs and AAs, there were no signiﬁcant differ-
ences in LD between cases and controls for thesemarkers
(data not shown).
Four ALDH2 markers, spanning 25,609 bp of the
gene on chromosome 12, cover 60% of the full length
of ALDH2 (table 2). LD analysis showed that these four
markers were in one haplotype block in both EAs and
AAs (ﬁg. 2). Two markers, T348C and T483C, are in
complete LD ( ). In both EAs and AAs, there were′D p 1
no signiﬁcant differences in LD between cases and con-
trols for these markers (data not shown).
The genotype frequency distributions of all markers
were in HWE in both EA and AA controls, but some
markers were in HWD in either EA or AA cases (table
3). In EAs, all ADH and ALDH markers were in HWE
in controls. However, many ADH markers were nomi-
nally in signiﬁcant ( ), modest ( ),P ! .03 .03  P  .05
or suggestive ( ) HWD in cases (table 3),.05 ! P ! .09
including ADH5∧SNP1, ADH1B∧SNP16 (Arg/His),
ADH1C∧SNP18 (Gln/Arg), and ADH1C∧SNP19. Seven
ADH4 markers were also in signiﬁcant HWD in cases,
as reported elsewhere.7 After correction formultiple test-
ing by use of SNPSpD (an effective Bonferroni-type cor-
rection that takes marker correlation into account),73
ADH1B∧SNP16 remained in signiﬁcant HWD (Pp
)..0001
In AAs, all ADH and ALDH markers were in HWE
in controls (except ADH1A∧SNP11 [ ], whichPp .044
we presume is because of its rare genotype frequency
and the small sample size). However, many ADH mark-
ers were nominally in signiﬁcant ( ), modestP ! .03
( ), or suggestive ( ) HWD in.03  P  .05 .05 ! P ! .09
cases (table 3), includingADH5∧SNP1,ADH1C∧SNP17
(Ile/Val), ADH1C∧SNP18 (Gln/Arg), ADH1C∧SNP19,
and ADH7∧SNP22 (Ala/Gly). After correction by SNP-
SpD, no markers remained in signiﬁcant HWD.
Genotypes of some ADH markers were associated with
AD (table 5). In EAs, the genotypes of ADH1B∧SNP16
were nominally associated with AD. (Genotypes of sev-
en ADH4 markers were also signiﬁcantly associated
with AD, as reported elsewhere.7) After correction by
SNPSpD, ADH1B∧SNP16 remained signiﬁcantly asso-
ciated with AD ( ).Pp .0013
In AAs, the genotypes of many markers were nomi-
nally signiﬁcantly ( ), modestly ( ),P ! .03 .03  P  .05
or suggestively ( ) associated with AD, in-.05 ! P ! .09
cluding ADH1B∧SNP14 (Arg/Cys), ADH1C∧SNP17,
ADH1C∧SNP18, ADH1C∧SNP19, and ADH7∧SNP20.
After multiple-comparison correction by SNPSpD, no
association remained signiﬁcant.
There are several peak J values among markers within
the ADH gene cluster and the ALDH2 gene for AD in
EAs and AAs (ﬁg. 3). In both EAs (ﬁg. 3) and AAs (not
shown), there are several peak J values among the ADH
markers that might indicate proximity of the risk alleles.
The highest J peak in the ADH gene cluster is at a
functional variant, ADH1B∧SNP16 (Arg/His) (FJFp
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Figure 4 Pairwise correlations between different genotypes (at the ADH5 and ADH6 genes), diplotypes (at other genes) in EAs (a) and
AAs (b). The gene names corresponding to the genotypes and diplotypes are shown on the axes, but the detailed names of genotypes and
diplotypes are not shown (the names of parts of the risk genotypes and diplotypes can be found in table 6). The colored scale denotes the
correlation coefﬁcient (r). This ﬁgure was generated using the program GOLD.74
in EAs and 1.000 in AAs). Other J peaks are11.667
at the following markers (grouped by gene): (1)
ADH5∧SNP1 ( in EAs and 0.439 in AAs),FJFp 0.051
(2) ADH1A∧SNP10 ( in AAs) andFJF p 1.000
ADH1A∧SNP11 (6.5 kb to SNP10) ( inFJFp 0.047
EAs), (3) ADH1B∧SNP13 ( in EAs) andFJFp 0.226
ADH1B∧SNP14 (551 bp to ADH1B∧SNP13) (FJFp
in AAs), (4) ADH1C∧SNP17 ( in0.112 FJFp 0.053
AAs) and ADH1C∧SNP18 (3.2 kb to SNP17) (FJFp
in EAs), and (5) ADH7∧SNP20 ( in0.072 FJFp 0.055
EAs) and ADH7∧SNP22 (AlarGly) ( inFJFp 1.000
AAs).
Peak J values among the ALDH2 markers were at
SNP24 ( in EAs) and SNP27 (FJFp 0.618FJFp 0.197
in AAs). We note that every gene had at least one marker
with a J peak.
Two ancestries were detected in our sample. The ge-
notypes of some ADHmarkers were associated with AD
after admixture effects were controlled for. These results
are almost completely consistent with, although less sta-
tistically signiﬁcant than, those from the aforementioned
case-control genotypewise analysis (table 5).
All subjects were assigned to two ancestral popula-
tions, Europeans and Africans; therefore, each subject
has two complementary ancestry proportions. Accord-
ing to the ancestry proportions, the mixed sample can
be separated into two distinct subpopulations: “genetic”
EAs (European ancestry proportion 10.5) and “genet-
ic” AAs (African ancestry proportion 10.5). The con-
cordances between the “genetic” status and the self-
reported ethnicity are 100% for EAs and 99.1% for
AAs. Among the “genetic” EA subjects, the admixture
degree is 1.7%; among the “genetic” AA subjects, the
admixture degree is 4.0% (more details given else-
where12). These two groups are quite distinct, not only
in their asymmetric ancestry proportions, but also in the
greatly different results from LD analysis, HWE tests,
and case-control association analysis.
SA analysis based on this structured sample showed
that, in “genetic” EAs, genotypes of ADH1B∧SNP16
were signiﬁcantly associated with AD ( ). InPp .007
“genetic” AAs, genotypes of many markers were nomi-
nally signiﬁcantly ( ), modestly ( ), orP ! .03 .03  P  .05
suggestively ( ) associated with AD, includ-.05 ! P ! .09
ing ADH1A∧SNP11, ADH1B∧SNP14, ADH1C∧SNP18
(Gln/Arg), and ADH7∧SNP20. After correction by
SNPSpD, no association remained signiﬁcant (table 5).
There were correlations between different diplotypes,
mainly within genes (ﬁg. 4). Within each population, the
results from correlation analyses in cases and controls
were similar. However, the correlations were quite dif-
ferent between populations. In EAs, there were sig-
niﬁcant diplotype-diplotype correlations within the
ADH1B, ADH1C, ADH7, and ALDH2 genes ( ;r 1 0.9
) but weak correlations between genes. In AAs,P ! .01
there were signiﬁcant diplotype-diplotype correlations
within the ADH1A, ADH1B, ADH1C, and ADH7
genes ( ; ). There were also diplotype-r 1 0.9 P ! .01
diplotype correlations between ADH1B and ADH7 in
AA cases.
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Table 6
DTR Analysis in EAs and AAs
Population and Variable f P b
EAs:
European ancestry … .0678 
Male … 1.7 # 107 
Age … 8.7 # 1029 
ADH5:
C/C … .0124 
ADH1A:
AGA/TGA .203 .0109 
AGA/TCG .181 .0108 
AGA/AGA .164 .0110 
TCG/TGA .109 .0108 
AGA/TGG .088 .0109 
TGA/TGA .060 .0109 
TCG/TGG .060 .0110 
TGA/TGG .057 .0108 
TCG/TCG .055 .0112 
ADH1B:
TCCG/CCTG .366 .0071 
CCTG/CCTG .075 .0945 
TCCA/TCCG .058 .0005 
ADH7:
ACGG/TCGA .036 .0590 
ALDH2:
ATTG/ATTG # ATTG/GCCAa … 4.6 # 109 
AAs:
Male … .0012 
Age … .0035 
ADH5:
T/T … .0042 
ADH5:
C/T … .0073 
ADH1A:
TCG/TCG .083 .0083 
TGA/TGA .059 .0451 
ADH1B:
TCCG/TCCG .425 .0106 
TTCG/TCCG .270 .0089 
TCCG/CCTG .113 .0100 
ADH7:
ACGG/TCGG .216 .0259 
ACGG/ACGG .124 .0425 
TCGG/TCGG .108 .0381 
TTGG/TCGG .057 .0265 
ALDH2:
GTTG/GCCA .197 .0306 
NOTE.—f p diplotype frequency in cases and controls for EAs and
AAs; b p regression coefﬁcient. Only the signs (not the values) of b
are shown. Positive () values of b reﬂect increased risk of the disorder
when the diplotype is present; negative () values reﬂect a protective
effect of the diplotype.
a “#” indicates interaction between diplotypes.
DTR analysis demonstrated that several genes studied
were risk genes for AD (table 6). In both EAs and AAs,
the genotypes of ADH5∧SNP1 and some diplotypes at
the ADH1A, ADH1B, ADH7, and ALDH2 genes were
associated with AD. Some of these risk diplotypes ex-
erted consistent effects on phenotype across EAs and
AAs. For example, the diplotype TCCG/CCTG at the
ADH1B gene protected against disease in both popu-
lations ( ). Some of the risk genotypes or diplotypesb ! 0
exerted opposite effects on phenotype in EAs and AAs.
For example, genotype C/C of ADH5∧SNP1 and all of
the diplotypes at ADH1A increased risk for disease in
EAs ( ) but protected against disease in AAs (b 1 0 b !
). Some of the risk diplotypes exerted effects on phe-0
notype in EAs only. For example, the diplotype CCTG/
CCTG at ADH1B and the diplotype ACGG/TCGA at
ADH7 increased risk for disease in EAs ( ). Theb 1 0
diplotype-diplotype interaction effects occurred mainly
in EAs. For example, the diplotype ATTG/ATTG and
the diplotype ATTG/GCCA at ALDH2 have interaction
effects on phenotype in EAs. Some of the risk diplotypes
exerted effects on phenotype in AAs only—for example,
the diplotypes TCCG/TCCG and TTCG/TCCG at
ADH1B and the diplotype TTGG/TCGG at ADH7 pro-
tected against disease ( ) in AAs, whereas the diplo-b ! 0
type TCGG/TCGG at ADH7 increased risk for disease
in AAs ( ). Table 6 lists only those variables thatb 1 0
remained in the last step of the DTR equations.
Discussion
Two main issues in this study warrant discussion: (1)
the implications of the results in terms of the gene-phe-
notype relationships and (2) the properties and advan-
tages of the DTR method. Some ADH and ALDH genes
have been shown by other studies to be important risk
factors for AD, mainly in Asians (table 1), but we show
that they are also important in EAs and AAs, and we
are the ﬁrst to show that other ADH and ALDH genes
are important for risk of AD in these two populations.
In the present study, we found, using DTR, associations
between AD and the ADH5, ADH1A, ADH1B, ADH7,
and ALDH2 genes, ﬁndings that are consistent with the
roles of ADH and ALDH isoenzymes in the metabolism
of alcohol. We expected to ﬁnd evidence of association
between ADH loci and AD, but the association was
surprisingly comprehensive.
These associations constitute an important part of the
genetic risk for AD. This is reﬂected both in the overall
attributable risk for this set of genes, each of which has
an independent contribution to disease, and in the fact
that this genomic region has consistently been identiﬁed
as one that harbors AD risk-affecting loci in linkage
studies.
DTR is a powerful method, and, in using it, we de-
tected associations that were not seen using many other
association methods, such as the HWD test, case-control
comparison, and SA. Several features make DTR more
powerful than other conventional association methods.
First, DTR allows use of a case-control sample, which
is easier than a family sample to collect and to expand
to reach sufﬁcient statistical power. Second, cases and
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controls, and even different populations, can be com-
bined in a single DTR model, thereby increasing sample
size and statistical power. Third, an unmatched case-
control design has been demonstrated to be more
powerful than a matched case-control design or a family-
based association design in detecting gene-gene inter-
actions, especially when the disease prevalence is mod-
erate (such as with AD).75 Fourth, different variables,
including different genotypes and diplotypes from dif-
ferent genes, can be entered into a single DTR model,
which avoids the multiple testing that leads to loss of
information. Fifth, DTR allows analysis even in the pres-
ence of deviation from HWE. Sixth, DTR allows diplo-
type phase to be uncertain (in the present study, the
maximal proportion of individuals with unambiguous
diplotypes [i.e., probability p 1] in a single gene was
only 37%; the proportion of individuals with unambig-
uous diplotypes across all the genes studied was only
15%). Seventh, DTR can control for population strat-
iﬁcation and admixture effects on association analysis
(assuming, of course, that ancestry coefﬁcients are avail-
able), and it allows for the control of other potential
confounders of association analysis, such as age and sex.
Eighth, DTR takes into account gene-gene interactions,
an approach that has been demonstrated to be more
powerful than single-locus analysis (despite correction
for multiple comparisons).76 Finally, DTR is able to ac-
count for LD effects and, additionally, cis-acting func-
tional effects. There is reason to believe that, in some
cases, cis-acting elements are mediating phenotypic ex-
pression (e.g., there are variants in the promoter of a
gene that inﬂuence the way other variants impact that
gene’s function, so that it is necessary to know, from a
functional standpoint, what speciﬁc variants are on each
chromosome). These may be detected by using diplo-
type-based (or haplotype-based) analytic approaches but
not by using other methods that employ multilocus ge-
notype data. On the basis of these considerations, ﬁnd-
ings obtained through application of DTR have a high
likelihood of being valid.
In our sample, the genotypes of all markers were in
HWE in controls, but some were in HWD in cases, in-
dicating the existence of associations between genes and
disease.7,57,58,77–81 Comparing the results of these HWD
tests with the case-control comparisons, we found two
things. First, the results from these methods are largely
consistent, which supports the notion that the HWD test
can be a valid association method, equivalent to a case-
control approach. Second, more markers were found to
be associated with phenotypes by the HWD test than
by case-control comparison, and P values generally were
lower by the HWD test than by case-control comparison.
Some P values greater than but close to .05 in the case-
control study were !.05 by the HWD test; thus, the
HWD test sometimes appears to be more powerful than
a case-control approach, which supports the conclusions
of Nielsen et al.77 and Luo et al.7 This may reﬂect a
recessive mode of inheritance.
Case-only studies and case-control studies are poten-
tially vulnerable to population stratiﬁcation, so all as-
sociation analyses were performed separately for EAs
and AAs. To control for admixture effects, SA was ap-
plied via the program STRAT, which gave results similar
to those obtained using a case-control comparison, in-
dicating that admixture effects were not strong in our
sample. We noted that many associations from theHWD
test, case-control comparison, and SA method became
nonsigniﬁcant after correction for multiple tests, which
indicates that these association methods often led to in-
formation loss. However, this information is preserved
using DTR, which does not require adjustment of sig-
niﬁcance level for multiple tests.
Under HWD, alleles and haplotypes are not indepen-
dent of one another. The effects of disease-predisposing
alleles and haplotypes may be “masked” by other non–
disease-predisposing alleles and haplotypes (i.e., epistatic
interactions).82 This may be particularly true for reces-
sive diseases, in which the non–disease-associated allele
obscures an effect of the disease-associated allele. There-
fore, allelewise and haplotypewise analyses might lose
power or otherwise be invalid.7,49 Since some of our
markers were in HWD, exploratory allelewise and hap-
lotypewise analyses were performed and showed fewer
and less signiﬁcant positive results than genotypewise
and diplotypewise analyses for our sample (authors’ un-
published data), which is consistent with conclusions
from our other studies7,11,12 about the relative power of
these methods in an HWD situation. Genotypewise and
diplotypewise analyses may be valid even under HWD,
and therefore they served as the primary analyses in the
present study.
The HWD test, case-control comparison, and SA anal-
yses cannot correct for interaction effects betweenmark-
ers and between genes. Diplotypes incorporate the LD
information from different markers, and the interactions
between diplotypes can be considered in the DTRmodel.
A diplotype is more representative of gene background
than is a single genotype, and diplotype-diplotype in-
teractions from different genes are more representative
of gene-gene interactions than are marker-marker inter-
actions. Therefore, DTR works well with respect to the
evaluation of gene-gene interactions.
Under HWD, the EM algorithm is not suitable for
reconstructing diplotypes. However, in the DTR model,
we used the diplotype probabilities predicted by the pro-
gram PHASE that waived the HWE assumption. When
the PHASE approach to haplotype reconstruction is
used, DTR is thus also independent of the HWE
assumption.
In summary, our ﬁndings by DTR analysis include the
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following points. (1) In EAs and/or AAs, the genotypes
of ADH5∧SNP1 and the diplotypes at the ADH1A,
ADH1B, ADH7, and ALDH2 genes are associated with
AD. Some associations are universal across both pop-
ulations. Some associations have opposite effects in dif-
ferent populations (suggesting that the actual risk-inﬂu-
encing variant is in a different phase in the two pop-
ulations, or, alternatively, that there are differing epi-
static effects). Some associations are population spe-
ciﬁc—that is, some associations appear only in EAs or
in AAs (table 6). (2) Most associations from DTR anal-
ysis are much more signiﬁcant than those from other
association methods. DTR detected strong associations
between ALDH2 and disease that were not observed at
all by use of other association methods—including a
multilocus genotype data analysis with a regression
method (the results of which were similar to the single-
locus genotype frequency analysis in table 5; data not
shown), which may reﬂect a cis-acting functional effect
in this gene. (3) The correlations between the genes are
weak. But within the genes, diplotype-diplotype corre-
lations are strong, which include those within ADH1A
in AAs, ALDH2 in EAs, and ADH1B, ADH1C, and
ADH7 in both populations (data not shown). Consid-
ering these correlations by DTR, only a signiﬁcant in-
teraction effect between two diplotypes within ALDH2
was detected in EAs (table 6). Additionally, we found
that ADH1C diplotypes were signiﬁcantly associated
with drug dependence, one of the disorders most com-
monly comorbid with AD (authors’ unpublished data).
Markers can be dependent on one another (i.e., cor-
related) without being in complete LD, or their depen-
dence may not be statistically signiﬁcant, so that the
effects of markers on traits can be decomposed intomain
effects and interaction effects. If an interaction effect is
strong, one marker can “mask” the main effect of an-
other marker.82 The interaction effect depends on the
correlation between markers and is related to the trait
of interest. Correlation between markers per se (such as
LD) depends on the physical distance between markers,
the allele frequencies of markers, population history, and
the nature of the traits, including the deﬁnition of phe-
notypes (e.g., mutation-related disease), sample size, and
ethnicity. Several of these factors—notably, allele fre-
quencies and population history—also vary between pop-
ulations. Therefore, the interaction effects of markers are
affected by many factors. Such effects may also be pop-
ulation-speciﬁc. In the present study, ADH1B∧SNP16
(Arg/His) was associated with AD in EAs ( ),Pp .001
and ADH1C∧SNP17 (Ile/Val) was associated with AD
in AAs ( ) (table 5). Our EA sample size was rel-Pp .040
atively large, and the correlation betweenADH1B∧SNP16
and ADH1C∧SNP17 was weak ( ;′ 2D p 0.758 r p
; ). In our AA sample, the corre-0.019 Pp .463 1 .05
lation between these two markers was also weak
( ; ; ; here, we in-′ 2D p 0.900 r p 0.004 Pp .231 1 .05
terpret the high D′ as being reﬂective of the different
allele frequencies for the two markers). Thus, the inter-
action effect of these two markers was weak, but the
main effect was strong in both populations (by use of
regression analysis). Even with this interaction effect
taken into account via stratiﬁcation analysis, as perOsier
et al.,14 the main effects of these two markers did not
change signiﬁcantly (data not shown), and the effect of
ADH1B∧Arg/His and that of ADH1C∧Ile/Val did not
modify each other signiﬁcantly in our samples. These
ﬁndings are not consistent with those reported by Os-
ier et al.,14 who claimed that the contribution of
ADH1C∧Ile/Val to risk for AD was actually attributable
to LD with ADH1B∧Arg/His in the Taiwanese Chinese
population. This inconsistency may result from the pop-
ulation speciﬁcity of the interaction effects; in other
words, this effect could be weak in EAs and AAs but
strong in Taiwanese Chinese.14 However, the conclusion
by Osier et al.14 may simply be incorrect, given the fol-
lowing points. (1) Their sample size ( ) wasnp 135
small. Such a sample size might result in type I error in
analysis of interaction effects. (2) The use of a stratiﬁ-
cation analytic method, and not a regression method, to
consider the marker-marker interaction effects could re-
duce power, because dividing the sample (i.e., into nine
subgroups based on three genotypes for each marker)
further reduces the sample size. Moreover, this should
have occasioned correction formultiple comparisons. (3)
The reported D′ of 0.77 between the ADH1B∧Arg/His
andADH1C∧Ile/Val variants14 does not constitute strong
enough disequilibrium for the markers to be in the same
haplotype block (as deﬁned by Gabriel et al.83); markers
should usually show higher LD to exert interaction ef-
fects on traits through that mechanism. Increasing the
sample size may help to clarify whether this D′ value
was accurate and whether such LD can result in as strong
an interaction effect in Taiwanese Chinese as that re-
ported by Osier et al.14 (4) Finally, twomarkers represent
only two points or two haplotype blocks in genes; a
marker-marker interaction effect is not sufﬁcient to rep-
resent a gene-gene interaction effect (that is, additional
markers at these two loci might not have any interaction
effects at all). It may therefore have been excessive to
state that the ADH1C gene exerted its effect via the
ADH1B gene in all populations, especially because the
authors tested only two markers in a small sample of a
speciﬁc population. Our design overcomes these partic-
ular limitations, and we were able to demonstrate that
these two genes exert independent main effects on phe-
notype—at least in EA and AA populations.
The multiplicity of gene effects that we observed (sev-
eral ADH genes and the ALDH2 gene were associated
with AD) conﬁrms that these disorders are multigenic—
minor effects from different genes produced additive ef-
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fects on risk for AD. This is consistent with the roles of
different ADH and ALDH isoenzymes in contributing
to alcohol metabolism (although different isoenzymes
have minor differences in the preferred substrates). Al-
though the activity of ADH1 enzyme (a subunit) is weak
in adults, the ADH1A gene still has effects on risk for
AD.
Replacing multilocus diplotypes with single-locus ge-
notypes in the DTR model can be done to ﬁne map the
risk locus (data not shown). One advantage of DTR as
a ﬁne-mapping method is that it allows for marker-
marker interactions, so that the confounding effects of
these interactions can be accounted for. However, DTR
ﬁne mapping is limited by the fact that it does not control
for the inﬂuence of the allele frequency of markers.12
The best approach for ﬁne mapping would be to com-
bine DTR with HWD measures—that is, use DTR to
screen potential susceptibility genes and then use an
HWD measure, such as the J value, to ﬁne map the risk
alleles within those genes. In the present study, the results
from ﬁne mapping with a J value (ﬁg. 3) are basically
consistent with those fromHWD tests (table 3) and case-
control comparisons (table 5).
We noted that every gene had at least one marker with
a J peak. This suggests that, despite the fact that LD is
sometimes present between markers at different genes,
association signals are actually originating within the
genes that show J peaks, which is consistent with the
DTR results. Interestingly, we localized some risk al-
leles close to well-known functional variants, such as
ADH1B∧SNP16 (Arg/His; previously called“ADH2*1/2”),
ADH1B∧SNP14 (Arg/Cys; previously called“ADH2*1/3”),
ADH1C∧SNP17 (Ile/Val; previously called “ADH3*1/2”),
and ADH7∧SNP22 (AlarGly), which is consistent with
ﬁndings from the existing literature (listed in table 1)
and supports the validity of our ﬁndings. Among these
peaks, the J value at ADH1B∧SNP16 for AD in EAs is
extremely high (11.667) and is consistent with the sig-
niﬁcance levels from HWD tests and case-control com-
parisons, suggesting either that this marker is extremely
close to the disease locus at the ADH1B gene or that
the marker might be the disease locus itself. In future
studies aimed at ﬁne mapping the risk alleles, a denser
set of markers at each risk gene will be required. This
is a necessary next step in understanding the complex
association between the genes encoding multiple al-
cohol-metabolizing enzymes and AD in a variety of
populations.
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